Illumina (NASDAQ:ILMN – Get Free Report) had its price objective hoisted by research analysts at Canaccord Genuity Group from $112.00 to $130.00 in a report issued on Monday,Benzinga reports. The firm presently has a “hold” rating on the life sciences company’s stock. Canaccord Genuity Group’s target price would suggest a potential downside of 3.55% from […]

Vera Therapeutics (NASDAQ:VERA – Get Free Report) had its price target hoisted by equities researchers at Bank of America from $48.00 to $66.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Bank of America‘s target price would suggest a potential upside of 29.07% […]

Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price objective raised by analysts at JPMorgan Chase & Co. from $65.00 to $67.00 in a research note issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the technology company’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 71.49% […]

Savara (NASDAQ:SVRA – Get Free Report) had its price objective boosted by Wells Fargo & Company from $7.00 to $9.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 48.39% from the stock’s current […]

Willow Lane Acquisition Corp. – Class A Ordinary Shares (NASDAQ:WLAC – Get Free Report) had its target price lifted by equities researchers at DA Davidson from $15.00 to $17.00 in a report issued on Wednesday. The brokerage currently has a “buy” rating on the stock. DA Davidson’s price objective would indicate a potential upside of […]

ArcBest (NASDAQ:ARCB – Get Free Report) had its price objective raised by equities research analysts at Stifel Nicolaus from $73.00 to $85.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the transportation company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 8.54% from the stock’s previous […]

Tesla (NASDAQ:TSLA – Get Free Report) had its price objective upped by investment analysts at Mizuho from $475.00 to $530.00 in a research note issued on Tuesday,MarketScreener reports. The firm presently has an “outperform” rating on the electric vehicle producer’s stock. Mizuho’s price target would indicate a potential upside of 12.30% from the company’s previous […]

Guardant Health (NASDAQ:GH – Get Free Report) had its target price raised by equities researchers at JPMorgan Chase & Co. from $90.00 to $120.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 15.40% from […]

Broadcom (NASDAQ:AVGO – Get Free Report) had its target price increased by stock analysts at TD Cowen from $405.00 to $450.00 in a research note issued on Friday. The firm currently has a “buy” rating on the semiconductor manufacturer’s stock. TD Cowen’s price target indicates a potential upside of 10.74% from the stock’s current price. […]

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its price target raised by stock analysts at Citizens Jmp from $141.00 to $167.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a “market outperform” rating on the stock. Citizens Jmp’s price objective suggests a potential upside of 41.98% from the stock’s previous close. […]

Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its target price upped by investment analysts at Needham & Company LLC from $120.00 to $145.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 21.35% […]

Booking (NASDAQ:BKNG – Get Free Report) had its price objective increased by equities researchers at Gordon Haskett from $5,620.00 to $5,710.00 in a report issued on Wednesday,MarketScreener reports. The brokerage currently has a “hold” rating on the business services provider’s stock. Gordon Haskett’s price objective indicates a potential upside of 11.49% from the company’s previous […]

Lucid Diagnostics (NASDAQ:LUCD – Get Free Report) had its price target increased by equities research analysts at Ascendiant Capital Markets from $8.00 to $8.25 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Several other equities analysts have also weighed in on the stock. […]

First Solar (NASDAQ:FSLR – Get Free Report) had its price target raised by stock analysts at Daiwa Capital Markets from $215.00 to $284.00 in a report issued on Tuesday,MarketScreener reports. The firm presently has an “outperform” rating on the solar cell manufacturer’s stock. Daiwa Capital Markets’ price target would indicate a potential upside of 10.99% […]